Navigation Links
Insulet Reports Fourth Quarter and Year End 2008 Results
Date:3/5/2009

Company Records 172% Year over Year Revenue Growth and First Full Quarter of Gross Profit

Carsten Boess to Lead Insulet's International Expansion

Brian Roberts Appointed CFO

BEDFORD, Mass., March 5 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System, today announced financial results for the fourth quarter and full year ended December 31, 2008.

Fourth Quarter 2008 Results

Fourth quarter 2008 revenue increased 172% to $11.9 million compared to $4.4 million in the fourth quarter of 2007. On a sequential basis, revenue increased 17% from $10.1 million in the third quarter of 2008. The Company added in excess of 2,200 new customers in the fourth quarter of 2008. The Company reported gross profit of $1.2 million or 10% in the fourth quarter of 2008 as compared to a gross loss of $2.3 million or (53%) in the fourth quarter of 2007 and a gross loss of $0.1 million or (1%) in the third quarter of 2008.

Net loss for the fourth quarter of 2008 was $28.3 million, or $1.02 per share, compared to a net loss of $15.7 million, or $0.59 per share, for the fourth quarter of 2007 and a net loss of $20.8 million, or $0.75 per share, in the third quarter of 2008. Net loss for the fourth quarter was negatively impacted by the recording of a restructuring charge of $8.2 million related to the Company's transition of its manufacturing activities to China. The restructuring charge is comprised of a $7.4 million non-cash write-down of manufacturing equipment at its Bedford headquarters and $0.8 million in severance related expenses.

Total operating expenses increased to $28.6 million in the fourth quarter of 2008, compared to $13.7 million in the fourth
'/>"/>

SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
2. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
3. Insulet Reports Third Quarter 2008 Results
4. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
5. Sally W. Crawford Joins Insulets Board of Directors
6. Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
7. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
8. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
11. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Five million Americans will buy a personal ... Liashek, owner of Studio South Fitness in ... at credentials and experience. The variation in education and ... trainer can pay $69.50 and get certified online in ... invest in themselves, A serious, professional trainer spends close ...
(Date:5/21/2013)... Third Generation Master Barber Greg Zorian is ... barbering DVDs. These DVDs include content from the HowToCutHair.tv ... cosmetology school or are current professionals, will no doubt ... teacher and mentor. , Today’s modern men’s hairstyles have ... 1960’s time period. In order to efficiently provide these ...
(Date:5/21/2013)... Tx. (PRWEB) May 21, 2013 Dallas-based ... peer- reviewed journal article testing the efficacy of their ... of eczema. The clinical study results appear in the ... , The article, “A Novel Sodium Hypochlorite Cleanser Shows ... Atopic Dermatitis,” reports impressive findings seen after consistent use ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading online ... the past year – and announced another milestone this ... efforts for Kids II, a designer of innovative baby ... local effort, specializing in search engine optimization (SEO) or ... website. The company now offers a host of boutique ...
(Date:5/21/2013)... Greenville, SC (PRWEB) May 21, 2013 ... be bringing the Philips Pocket Memo 8000, the newest ... around the country, providing a top-notch product for anyone ... recorder. The Pocket Memo 8000 is ... area few of the all-new digital voice recorder features ...
Breaking Medicine News(10 mins):Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 2Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 2Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 4Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 5Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 6Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2
... ... ... 1, 2010 -- JPay.com, the Trusted Leader in Offender Services, has brought their pioneering ... cost to correctional departments and today announced the newest member of the JPay family, ...
... new study adds to the mounting evidence that older adults ... inadequacy may be a risk factor for the metabolic syndrome, ... were presented at The Endocrine Society,s 92nd Annual Meeting in ... of diabetes and cardiovascular disease, an adequate vitamin D level ...
... ... in the United States we,re still seeing discriminatory actions towards the medicine. ... discrimination as at the young age of 30 he fights Cancer and a ... his job for using medicinal marijuana and the American Civil Liberties Union is ...
... ... to attract patients, compete effectively, grow their revenues, counter the declining economy and prepare ... ... doctor and physician marketing firm Heathcare Success Strategies , doctors are increasingly resorting to ...
... BruxZir Solid Zirconia, ... bridge with no porcelain overlay. This new restoration proves strong, reliable and esthetic because of ... ... innovation from Glidewell Dental Lab , is a full-contour solid zirconia crown or bridge ...
... ... company specializing in threat prevention and cloud based antivirus solutions, announced today the launch ... cross carrier and worldwide with Google reporting 60,000 Android handsets shipped each day., ... (PRWEB) July 1, ...
Cached Medicine News:Health News:JPay, the Apple of Washington State DOC's eye 2Health News:Low vitamin D linked to the metabolic syndrome in elderly people 2Health News:Fired Wal-Mart Employee Accepts Full Scholarship to The Medical Marijuana Academy 2Health News:Doctors and Medical Groups Increasingly Embrace Physician Marketing to Counter Changes in Health Care 2Health News:Strength Based on Science Drives Glidewell Dental Lab's BruxZir Solid Zirconia 2Health News:Strength Based on Science Drives Glidewell Dental Lab's BruxZir Solid Zirconia 3Health News:Strength Based on Science Drives Glidewell Dental Lab's BruxZir Solid Zirconia 4Health News:Bluepoint Security Launches World's First Cloud Antivirus For The Google Android Mobile Platform 2
(Date:5/21/2013)... 2013  Lehigh Valley Health Network has announced the ... adding to its existing arsenal of five 5-foot-5 germ-killing ... within the network, LVHN is now deploying the largest ... superbugs and provide the best possible patient care available. ... TRU-D – the signature product of Memphis ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013  BioRestorative Therapies, Inc. ... sciences company focused on developing stem cell based therapies ... Weinreb , its President and CEO, will be ... The conference will be held on Thursday, May 30, ... E 42nd Street in New York City.  Mr. Weinreb,s ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... , , , ... academic, private and government cancer drug discovery efforts , ... Research Institute today announced that it has been selected as ... Institute,s (NCI) Chemical Biology Consortium (CBC)--a program meant to coordinate ...
... , , , ... N.J., Aug. 19 Newly published data in The New ... (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen ... , The data include an analysis from the ...
Cached Medicine Technology:Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 2Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 3Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 2Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 3Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 5Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 6Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 7Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 8Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 9
... Cauteries provide a broad selection ... in a wide variety of ... cautery is packaged sterile, complete ... lock switch in the "off ...
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
Medicine Products: